An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis
Lili Cui(Naval Medical Research Command), Keshen Li(First Affiliated Hospital of Jinan University), Hua Tao(Guangdong Medical College), Guoda Ma(Guangdong Medical College), Qunwen Pan(Guangdong Medical College), Wanwen Cheng(Guangdong Medical College), Yu Liu(Nanjing Medical University), You Li(Guangdong Medical College), Tingting Liu(Guangdong Medical College), Gen Liu(Guangdong Medical College), Zhou Liu(Xuzhou Medical College), Yiming Shao(Guangdong Medical College), Yan Wang(Liaoning Academy of Agricultural Sciences), Yujie Cai(Guangdong Medical College), Bin Zhao(Guangdong Medical College), Xin Shao(Guangdong Medical College), Yan Gao(Beijing Shijitan Hospital), Yuliu Xie(Guangdong Medical College), Xiaotang Ma(Guangdong Medical College)
Cited by 42
Related Papers
Comorbidities and multi-organ injuries in the treatment of COVID-19
|The Lancet|2020|669
Dravet syndrome patient‐derived neurons suggest a novel epilepsy mechanism
|Annals of Neurology|2013|244
Emergence of Community-Acquired Adenovirus Type 55 as a Cause of Community-Onset Pneumonia
|CHEST Journal|2013|115
MicroRNA-146a Is a Wide-Reaching Neuroinflammatory Regulator and Potential Treatment Target in Neurological Diseases
|Frontiers in Molecular Neuroscience|2020|102
Status and Challenges of Public Health Emergency Management in China Related to COVID-19
|Frontiers in Public Health|2020|89